Amid threats to his life over Covishield vaccine supplies, the CEO of Serum Institute of India, the world's largest vaccine maker, has got Y category security. The centre granted SII CEO Adar Poonawalla enhanced security cover by the CRPF amid widespread anger over the pricing of the vaccine made by...
Serum Institute CEO Adar Poonawalla tweeted Monday to reassure Covishield-vaccinated Indians facing issues with travel to the European Union - in light of the EU's new 'vaccine passport' scheme not recognising the drug. Poonawalla said he had taken this up at the highest levels" and that he hoped the matter would be resolved soon.
#AdarPoonawalla #Covidshield #EUTravel
A man in Lucknow has filed a complaint against Serum Institute of India CEO Adar Poonawalla and others, alleging that he did not develop antibodies despite taking a Covishield dose. The complaint has been filed at Aashiana police station in Lucknow. Meanwhile, the complainant has threatened to move court if an FIR is not registered against the people mentioned in his complaint.
#AdarPoonawalla #Covidshield #SerumInstitute
Today, the health ministry said that the predictions about the third wave of Covid should be taken very seriously; Sources in the Serum Institute of India said that the production of Covishield has been ramped up to around 110 million doses this month; Today, the Finance Ministry said that keeping in mind the growing demand for holding clerical cadre examinations in public sector banks in local or regional languages, a committee has been formed to look into the matter; Today, Congress slammed the Centre over the surge of prices of petrol and diesel in the country.
#CovidThirdWave #Predictions #CovidNorms
Serum Institute of India's Covishield vaccine has been approved in seven European Union nations and Switzerland amid a row over travel pass. Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain are confirmed as including Covishield.
#EU #Covidshield #Covid19
The Subject Expert Committee of the Central Drugs Standard Control Organisation did not approve Serum Institute of India’s request to allow clinical trials of its second Covid vaccine in children.
#SII #CDSCO #Covovax